FDA Study: Competitive Generics Launch Faster Than Other Generics
21 Nov 2025 //
RAPS
Manufacturing permissions after lapse of new drug status
18 Nov 2025 //
EXPRESSPHARMA
Cosmo, Glenmark Obtain European Market Approval For Winlevi
18 Nov 2025 //
EXPRESSPHARMA
Genentech`s Giredestrant Shows Superior iDFS in Breast Cancer
18 Nov 2025 //
BUSINESSWIRE
Indian Pharma Sector Poised for A Global Leap Beyond Generics
17 Nov 2025 //
INDPHARMAPOST
Lupin Launches Long-Acting Risperidone In US
15 Nov 2025 //
PRESS RELEASE
Zydus Gets FDA Nod For Diroximel Fumarate Capsules
14 Nov 2025 //
INDPHARMAPOST
Zydus Lifesciences Receives USFDA Approval For Leuprolide Acetate
14 Nov 2025 //
ECONOMICTIMES
Amneal Receives U.S. FDA Approval For Iohexol Injection
13 Nov 2025 //
GLOBENEWSWIRE
Ingenus Pharma Launches First Generic Equivalent To Premarin
13 Nov 2025 //
PR NEWSWIRE
Alembic Gets USFDA Nod For Dexlansoprazole Delayed-Release
13 Nov 2025 //
EXPRESSPHARMA
Padagis Awarded New York Department of Health Naloxone Contract
12 Nov 2025 //
PR NEWSWIRE
Mallinckrodt Spins Off Par Health, Launches Keenova Therapeutics
10 Nov 2025 //
PR NEWSWIRE
Alembic Gets FDA Final Nod For Sumatriptan Injection USP
09 Nov 2025 //
INDPHARMAPOST
Alembic Announces USFDA Final Approval For Dasatinib Tablets
08 Nov 2025 //
INDPHARMAPOST
National Pharmaceutical Pricing Authority Sets Retail Prices
06 Nov 2025 //
PHARMABIZ
Venus Remedies Launches Methotrexate, Cefuroxime, And Irinotecan
06 Nov 2025 //
EXPRESSPHARMA
Zydus Gets FDA Tentative Approval For 4mg Budesonide Capsules
05 Nov 2025 //
INDPHARMAPOST
Meitheal Pharmaceuticals Receives Approval from US FDA Contepo
04 Nov 2025 //
BUSINESSWIRE
Glenmark To Launch Generic Drug To Treat Metabolic Acidosis In US
04 Nov 2025 //
PR NEWSWIRE
Breckenridge Launches 1mg Everolimus Tablets, Generic Zortress
30 Oct 2025 //
PR NEWSWIRE
Ritedose Gets FDA Nod For Generic Tobramycin Inhalation Solution
30 Oct 2025 //
GLOBENEWSWIRE
Alembic Pharma Gets USFDA Nod For 60mg Ticagrelor Tablets
29 Oct 2025 //
EXPRESSPHARMA
Amneal Gets FDA Tentative Approval For Beclomethasone Aerosol
29 Oct 2025 //
GLOBENEWSWIRE
Padagis Invests $36M+ To Expand U.S. Manufacturing
28 Oct 2025 //
PR NEWSWIRE
Zydus Gets Health Canada Approval For Mesalamine Suppositories
27 Oct 2025 //
INDPHARMAPOST
Teva Settles Asthma Inhaler Antitrust Lawsuit For $35M
27 Oct 2025 //
REUTERS
FDA Urges Pharma Companies To Finish Nitrosamine Risk Assessments
27 Oct 2025 //
RAPS
Qilu Pharma Files Abbreviated NDA for Exparel
27 Oct 2025 //
GLOBENEWSWIRE
CF Buyers Club Aims To Grow Access To Vertex`s Trikafta
24 Oct 2025 //
FIERCE PHARMA
Glenmark Pharma USA To Launch Ropivacaine Hydrochloride
24 Oct 2025 //
INDPHARMAPOST
FDA Approves Caplin Steriles` ANDA For Nicardipine Hydrochloride
24 Oct 2025 //
INDPHARMAPOST
Lupin Launches Authorized Generic Of Ravicti In US
24 Oct 2025 //
INDPHARMAPOST
Dr Reddy`s Gets Nod To Make Generic Semaglutide For Weight Loss
24 Oct 2025 //
ECONOMICTIMES
Branded Legacy Advances Intranasal Naloxone Spray With FDA
22 Oct 2025 //
GLOBENEWSWIRE
Pacira Bio Sciences Notified of ANDA Filing from Exparel
21 Oct 2025 //
GLOBENEWSWIRE
High-Quality Data Is Essential for AI Tools for Generic Drugs
21 Oct 2025 //
RAPS
Novo`s Rybelsus Gains FDA Expansion To Reduce Risk Of MACE
21 Oct 2025 //
FIERCE PHARMA
Endo Introduces Sole Generic RAVICTI Oral Liquid in US
20 Oct 2025 //
PR NEWSWIRE
Sunshine Launches STD, Acne & Lyme Disease Therapy Doxycycline
20 Oct 2025 //
PHARMIWEB
FDA Approves Alembic`s Triamcinolone Acetonide Injectable
19 Oct 2025 //
INDPHARMAPOST
Strides and Incepta Partner to Expand Women’s Health Access
17 Oct 2025 //
PRESS RELEASE
Roche`s Appeal Denied By Supreme Court In Risdiplam Generic Drug
17 Oct 2025 //
BUSINESS STD
Sunshine Bio Launches Cholesterol Drug Pravastatin
16 Oct 2025 //
PHARMIWEB
Roche Challenges Natco`s Generic Risdiplam Launch In India
14 Oct 2025 //
ECONOMICTIMES
Aspen Wins Approval to Market Lilly`s Mounjaro in South Africa
13 Oct 2025 //
REUTERS
Moderna Claims Early Victory For Cancer Antigen In Melanoma
13 Oct 2025 //
BIOSPACE
Natco Wins Patent Battle To Launch Generic `Risdiplam`
11 Oct 2025 //
ECONOMICTIMES
Tariff Pause Eases Pressure On Drug Companies
11 Oct 2025 //
ECONOMICTIMES
Trump & Co Halts Generic Drug Tariffs, Boosts Indian Pharma Stock
09 Oct 2025 //
ECONOMICTIMES
Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers
07 Oct 2025 //
FIERCE PHARMA
Biocon Unit Gets USFDA Nod For Genetic Anti-Bacterial Drug
07 Oct 2025 //
ECONOMICTIMES
Pharmanovia Appoints Stephan Eder As CEO
07 Oct 2025 //
INDPHARMAPOST
Zydus Gets Health Canada Approval For Liothyronine Tablets
07 Oct 2025 //
INDPHARMAPOST
Kennedy Push For Autism Drug Gets A Boost From Pharma
06 Oct 2025 //
REUTERS
Zydus Lifesciences Gets USFDA Nod For Deflazacort Oral Suspension
06 Oct 2025 //
ECONOMICTIMES
Supreme Court Rejects Purdue`s Oxycontin Patent Appeal
06 Oct 2025 //
REUTERS
FDA Confirms Para IV Patent Litigation for Korsuva
06 Oct 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Welireg
06 Oct 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Nourianz
06 Oct 2025 //
FDA

Market Place
Sourcing Support